For: | Mahmoudvand S, Shokri S, Taherkhani R, Farshadpour F. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma. World J Gastroenterol 2019; 25(1): 42-58 [PMID: 30643357 DOI: 10.3748/wjg.v25.i1.42] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i1/42.htm |
Number | Citing Articles |
1 |
Kevin Dzobo. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. OMICS: A Journal of Integrative Biology 2021; 25(6): 358 doi: 10.1089/omi.2021.0052
|
2 |
Yasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, Kenji Fukumoto, Makiko Urabe, Katsuhiko Sato, Yuta Myojin, Akira Doi, Kazuhiro Murai, Sadatsugu Sakane, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83082-7
|
3 |
Noé Velázquez-Márquez, Laura Cristina Huelgas-Saavedra. Pathogens Associated with the Development of Cancer in Humans. 2024; : 1 doi: 10.1007/978-3-031-62558-9_1
|
4 |
Hyunyoung Yoon, Kyung Lib Jang. Hydrogen Peroxide Inhibits Hepatitis C Virus Replication by Downregulating Hepatitis C Virus Core Levels through E6-Associated Protein-Mediated Proteasomal Degradation. Cells 2023; 13(1): 62 doi: 10.3390/cells13010062
|
5 |
Shahab Mahmoudvand, Somayeh Shokri. Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19. Scandinavian Journal of Immunology 2021; 94(4) doi: 10.1111/sji.13044
|
6 |
Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello. GSK-3 in liver diseases: Friend or foe?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020; 1867(9): 118743 doi: 10.1016/j.bbamcr.2020.118743
|
7 |
Kazim Yalcin Arga, Medi Kori. Oncogenic Viruses. 2023; : 221 doi: 10.1016/B978-0-12-824156-1.00009-1
|
8 |
Dina Mofed, Salwa Sabet, Ahmed A. Baiomy, Tamer Z. Salem. The Transgene Expression of the Immature Form of the HCV Core Protein (C191) and the LncRNA MEG3 Increases Apoptosis in HepG2 Cells. Current Issues in Molecular Biology 2022; 44(8): 3632 doi: 10.3390/cimb44080249
|
9 |
Iman H. Ibrahim, Ola Sayed M. Ali, Adel A. El-Sahar, Mohamed Elrefaei, Nabila El-Sheikh. Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients’ PBMCs. Journal of Clinical and Experimental Hepatology 2023; 13(6): 1008 doi: 10.1016/j.jceh.2023.06.004
|
10 |
Hemalatha Mani, Jui-Hung Yen, Hao-Jen Hsu, Chun-Chun Chang, Je-Wen Liou. Hepatitis C virus core protein. Tzu Chi Medical Journal 2022; 34(2): 139 doi: 10.4103/tcmj.tcmj_97_21
|
11 |
Ruimin Liu, Yan Sun, Shuai Chen, Yun Hong, Zhongxian Lu. FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis. The FEBS Journal 2022; 289(15): 4536 doi: 10.1111/febs.16403
|
12 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 63 doi: 10.1016/B978-0-323-99283-1.00012-4
|
13 |
Necla Kulabaş, Jin-Ching Lee, Özlem Bingöl Özakpınar, İlkay Küçükgüzel. Synthesis and anti-HCV activity of novel 5-arylmethylene-1,3-thiazolidin-4-one derivatives via suppression of NS5B polymerase and COX-2. Journal of Molecular Structure 2024; 1311: 138407 doi: 10.1016/j.molstruc.2024.138407
|
14 |
Pankaj Trivedi, Sandesh Kumar Patel, Diana Bellavia, Elena Messina, Rocco Palermo, Simona Ceccarelli, Cinzia Marchese, Eleni Anastasiadou, Lisa M. Minter, Maria Pia Felli. When Viruses Cross Developmental Pathways. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.691644
|
15 |
Shaian Tavakolian, Seidamir Pasha Tabaeian, Abolfazl Namazi, Ebrahim Faghihloo, Abolfazl Akbari. Role of the VEGF in virus‐associated cancers. Reviews in Medical Virology 2024; 34(1) doi: 10.1002/rmv.2493
|
16 |
Fatemeh Farshadpour, Reza Taherkhani, Farkhondeh Bakhtiari, Haruki Komatsu. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9294276
|
17 |
Chia-Chi Wang, Kuo-Chih Tseng, I-Shiang Tzeng, Jia-Horng Kao. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association 2021; 120(3): 965 doi: 10.1016/j.jfma.2020.10.015
|
18 |
Habibollah Mirzaei, Saeed Ghorbani, Sayyad Khanizadeh, Haideh Namdari, Ebrahim Faghihloo, Abolfazl Akbari. Histone deacetylases in virus‐associated cancers. Reviews in Medical Virology 2020; 30(1) doi: 10.1002/rmv.2085
|
19 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
20 |
Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jilkova, Samia Afzal. Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers 2023; 3(1): 82 doi: 10.3390/livers3010008
|
21 |
Lap P. Nguyen, Tram T. T. Nguyen, Huu C. Nguyen, Hang T. Pham, Kang Min Han, Dong Hwa Choi, Eun-Mee Park, Sang Min Kang, Dongseob Tark, Yun-Sook Lim, Soon B. Hwang, J.-H. James Ou. Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly. Journal of Virology 2020; 94(19) doi: 10.1128/JVI.01306-20
|
22 |
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell Culture. Journal of Molecular Biology 2022; 434(7): 167501 doi: 10.1016/j.jmb.2022.167501
|
23 |
Tadej Strojnik. Advanced Concepts and Strategies in Central Nervous System Tumors [Working Title]. 2024; doi: 10.5772/intechopen.1006516
|
24 |
H.H. Rashwan, A.M. Taher, H.A. Hassan, A.A. Awaji, C.J. Kiriacos, R.A. Assal, R.A. Youness. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice 2024; 256: 155223 doi: 10.1016/j.prp.2024.155223
|
25 |
Shahab Mahmoudvand, Somayeh Shokri, Mohsen Nakhaie, Farid Azizi Jalilian, Ameneh Mehri-Ghahfarrokhi, Reza Yarani, Ali Shojaeian. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00471-x
|
26 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7): 1632 doi: 10.3390/microorganisms11071632
|
27 |
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article. International Journal of Molecular Sciences 2023; 24(22): 16048 doi: 10.3390/ijms242216048
|
28 |
Jili Wang, Shanshan Qu, Qinyan Xu, Zhaofeng Jin, Tian Li, Shuxian Zhang, Xihe Sun, Qingbin Cui. Correlation Analysis between Retention of Gd-DTPA in the Cystic Area of Brain Metastasis and MRI Signs. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2738892
|
29 |
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Juliana Marisol Godínez-Rubí, Sarai Citlalic Rodríguez-Reyes, Erika Martínez-López, Guillermo M. Zúñiga-González, Laura Verónica Sánchez-Orozco. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats. International Journal of Molecular Sciences 2023; 24(9): 8387 doi: 10.3390/ijms24098387
|
30 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21): 13612 doi: 10.3390/ijms232113612
|
31 |
Fei Feng, Yue Zhao. Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment. Medical Principles and Practice 2024; 33(5): 414 doi: 10.1159/000539349
|
32 |
Effi Haque, M. Rezaul Karim, Aamir Salam Teeli, Magdalena Śmiech, Paweł Leszczynski, Dawid Winiarczyk, Emil D. Parvanov, Atanas G. Atanasov, Hiroaki Taniguchi. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis. International Journal of Molecular Sciences 2020; 21(15): 5378 doi: 10.3390/ijms21155378
|
33 |
Mubarak A. Alamri. Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma. Saudi Pharmaceutical Journal 2023; 31(6): 1125 doi: 10.1016/j.jsps.2023.04.003
|
34 |
Hong Zhao, Yujie Wang, Yufeng Liu, Xiaohua Hao, Hongshan Wei, Wen Xie. The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular Mechanism. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/5901083
|
35 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
|
36 |
Medi Kori, Kazim Yalcin Arga. Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics. Expert Review of Anticancer Therapy 2022; 22(11): 1211 doi: 10.1080/14737140.2022.2139681
|
37 |
Jenny Paola Alfaro-García, María Camila Granados-Alzate, Miguel Vicente-Manzanares, Juan Carlos Gallego-Gómez. An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks. Cells 2021; 10(11): 2863 doi: 10.3390/cells10112863
|
38 |
Decebal Fodor, Ioan Jung, Sabin Turdean, Catalin Satala, Simona Gurzu. Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study. World Journal of Hepatology 2019; 11(3): 294-304 doi: 10.4254/wjh.v11.i3.294
|
39 |
Abbasi Majid, Jinxia Wang, Muhammad Nawaz, Sattar Abdul, Munawar Ayesha, Chunmei Guo, Qinglong Liu, Shuqing Liu, Ming-Zhong Sun. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00223
|
40 |
Lu Zhao, Xiaojie Sun, Luhua Chen, Xiaoyan Feng, Xiqin Yang, Peng Zou, Xialu Wang, Rong Zhang. Hepatitis C Virus Core Protein Promotes the Metastasis of Human Hepatocytes by Activating the MAPK/ERK/PEA3-SRF/c-Fos/MMPs Axis. Archives of Medical Research 2022; 53(5): 469 doi: 10.1016/j.arcmed.2022.06.004
|
41 |
Shahab Mahmoudvand, Somayeh Shokri, Azarakhsh Azaran, Seyed S. Seyedian, Manoochehr Makvandi, Habibollah Mirzaei, Sheida B. Sheikhrobat. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study. Therapeutic Apheresis and Dialysis 2021; 25(2): 218 doi: 10.1111/1744-9987.13535
|
42 |
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
|
43 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021; 81(4): 419 doi: 10.1007/s40265-020-01458-x
|
44 |
Pan Song, Zirui Gao, Yige Bao, Li Chen, Yuhe Huang, Yanyan Liu, Qiang Dong, Xiawei Wei. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01563-4
|
45 |
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
|
46 |
K.T. Nachammai, R. Srinithi, P. Sangavi, R. Sangeetha, S. Gowtham Kumar, R. Lakshmi Sundaram, Kulanthaivel Langeswaran. Phospholipases in Physiology and Pathology. 2023; : 219 doi: 10.1016/B978-0-323-95697-0.00008-X
|
47 |
Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Nobuhiro Kobayashi, Atsuya Yamashita, Takasuke Fukuhara, Akihide Ryo, Moto Fukai, Akinobu Taketomi, Yoshiharu Matsuura, Kohji Moriishi. Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses. Hepatology Communications 2021; 5(4): 634 doi: 10.1002/hep4.1653
|
48 |
Virginia Sedeño-Monge, Francisca Sosa-Jurado, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Gerardo Santos-López. Pathogens Associated with the Development of Cancer in Humans. 2024; : 71 doi: 10.1007/978-3-031-62558-9_4
|
49 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
50 |
Hirotake Kasai, Atsuya Yamashita, Yasunori Akaike, Tomohisa Tanaka, Yoshiharu Matsuura, Kohji Moriishi, Marthandan Mahalingam, Swati Jain. HCV infection activates the proteasome via PA28γ acetylation and heptamerization to facilitate the degradation of RNF2, a catalytic component of polycomb repressive complex 1. mBio 2024; 15(11) doi: 10.1128/mbio.01691-24
|
51 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
|
52 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 83 doi: 10.1016/B978-0-323-98807-0.00003-X
|
53 |
Shehua Qian, Olga Golubnitschaja, Xianquan Zhan. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA Journal 2019; 10(4): 365 doi: 10.1007/s13167-019-00194-x
|
54 |
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, Armin Khaghani Boroujeni, Somayeh Shokri, Shahab Mahmoudvand. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.147
|
55 |
Savvina Moustafa, Katerina Kassela, Maria Bampali, Nikolas Dovrolis, Athanassios Kakkanas, Apostolos Beloukas, Penelope Mavromara, Ioannis Karakasiliotis. Hepatitis C Core Protein Induces a Genotype-Specific Susceptibility of Hepatocytes to TNF-Induced Death In Vitro and In Vivo. Viruses 2022; 14(11): 2521 doi: 10.3390/v14112521
|
56 |
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis. Journal of Cellular Physiology 2019; 234(9): 14734 doi: 10.1002/jcp.28249
|